Dale Cooke

Dale Cooke is president of PhillyCooke Consulting, which helps companies use 21st century technology to communicate about FDA-regulated products while remaining compliant with regulations written in the 1960s. Dale has worked with more than 40 pharmaceutical and medical device clients and nearly 20 advertising agencies around the world. His insights have been featured in the Wall Street Journal’s Health blog, The Pink Sheet, MedAdNews, PharmExec, and others. Dale is an active member of the Regulatory Affairs Professionals Society (RAPS), Drug Information Association (DIA), Food and Drug Law Institute (FDLI), and the Alliance for a Stronger FDA.

Dale is the author of Effective Review and Approval of Digital Promotional Tactics, now in its second edition, which is part of FDLI’s primer series. He is regularly invited to speak at industry conferences on topics including FDA enforcement trends, best practices for review processes, global review practices, and life sciences use of social media.

Dale earned his B.A. in Philosophy from Southern Methodist University, an M.A. in Analytical Philosophy from the University of Arizona, and studied Epidemiology and Biostatistics at Drexel University’s School of Public Health and Healthcare Compliance at Seton Hall University’s School of Law. Dale is currently enrolled at Drexel University’s Thomas Kline School of Law with anticipated JD completion in 2019.

Courses Taught